Literature DB >> 29178223

Synthesis of Methyl 5'-Thio-α-isomaltoside via an Acyclic Monothioacetal and its Behavior toward Glucoamylase.

Hironobu Hashimoto1, Masashi Kawanishi1, Hideya Yuasa1.   

Abstract

Methyl 5'-thio-α-isomaltoside (1), which contains the ring-sulfur analogue of the nonreducing glucoside of isomaltose, was synthesized from gentiobiose through a novel ring opening-recyclization approach. The nonreducing glucoside of per-O-benzylated phenyl 1-thio-β-gentiobioside underwent O-5'-C-1' bond cleavage with dimethyl-boron bromide and thiolacetic acid to give the acyclic monothioacetal 4 with the 1-thioglucopyranoside at the reducing end intact. The HO-5' group in 4 was inverted by a standard oxidation-reduction process with good efficiency. Recyclization under Mitsunobu condition allowed C-5'-S-1' bond formation with inversion of configuration at C-5', to give 1 after functional group interconversion. TLC analysis showed that 1, unlike isomaltose, was not hydrolyzed by glucoamylase from Rhizopus niveus. A fluorometric assay confirmed that the dissociation constant (Kd ) for 1 with the enzyme was 39 mM at 20°C, which is comparable with that for isomaltose. A binding assay involving fluorescence titration of the enzyme-1 complex with gluconolactone indicated that the disaccharide 1 was bound to the catalytic and noncatalytic subsites. Since isomaltose is known to bind only to the noncatalytic subsites, this result indicates a relatively high affinity of the 5-thioglucose moiety for the catalytic subsite.
Copyright © 1996 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  binding studies; glucoamylase; isomaltoses; oligosaccharides; thiosugars

Year:  1996        PMID: 29178223     DOI: 10.1002/chem.19960020515

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Stereoselective synthesis of (+)-5-thiosucrose and (+)-5-thioisosucrose.

Authors:  Atsushi Ueda; Jinhong Pi; Yui Makura; Masakazu Tanaka; Jun'ichi Uenishi
Journal:  RSC Adv       Date:  2020-03-06       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.